I wouldn't be surprised if the publication is unreasonably delayed due to BP exerting is influence. Maybe BP is a big funder or advertiser of certain journals? You know, sh*t like that.

We'll see. Dr. P should at least have had some responses from peers by now.

I'm also looking forward to the PRs naming the IB who's gonna take CYDY out of penny land and to the PRs naming the distribution partners. The quality of these organizations will have an impact to investors' perception of the legitimacy of leronlimab and Cytodyn.